NULL

NULL

NULL

NULL

NULL

NULL

NULL

Bioactive films with a nanoplate structure were prepared on the surface of a biodegradable AZ31B magnesium (Mg) alloy via anodization in simulated body fluid (SBF) as an electrolyte to control Mg biodegradability and improve surface bioactivity. The effect of the electrolyte temperature and pH values on the formation of the biomimetic film were studied. The electrolyte was set at three different temperatures of 37, 50, and 80
C, with pH values ranging from 7.4 to 8 for the lower electrolyte temperature and 11.5–12 for the two higher levels of temperature. The apatite films on the different samples were characterized using X-ray diffraction spectroscopy (XRD), field emission scanning electron microscopy (FE-SEM), EDS element mapping, X-ray photon spectroscopy (XPS), and FTIR spectroscopy. The water contact angles of the different surfaces were evaluated, moreover, the corrosion behaviors of the different samples were studied using electrochemical potentiodynamic DC, electrochemical impedance spectroscopy (EIS), and immersion tests. The human fetal-osteoblast cell line hFOB 1.19 was used in a cell culture test, and the biological response and cell function were evaluated in vitro using DNA and PCR. The decomposition of the apatite film was affected by the anodization electrolyte temperature, resulting in an amorphous structure. It is observed that the apatite structure has nanoplates at electrolyte temperature (37 to 50)
C and these have a tendency to disappear at 80
C.

Poly(lactic acid) (PLA) nanofiber scaffold has received increasing interest as a promising material for potential application in the field of regenerative medicine. However, the low hydrophilicity and poor ductility restrict its practical application. Integration of hydrophilic elastic polymer onto the surface of the nanofiber scaffold may help to overcome the drawbacks of PLA material. Herein, we successfully optimized the parameters for in situ deposition of poly(vinyl alcohol), (PVA) onto post-electrospun PLA nanofibers using a simple hydrothermal approach. Our results showed that the average fiber diameter of coated nanofiber mat is about 1265±222 nm, which is remarkably higher than its pristine counterpart (650±180 nm). The hydrophilicity of PLA nanofiber scaffold coated with a PVA thin layer improved dramatically (36.11±1.5°) compared to that of pristine PLA (119.7±1.5°) scaffold. The mechanical testing showed that the PLA nanofiber scaffold could be converted from rigid to ductile with enhanced tensile strength, due to maximizing the hydrogen bond interaction during the heat treatment and in the presence of PVA. Cytocompatibility performance of the pristine and coated PLA fibers with PVA was observed through an in vitro experiment based on cell attachment and the MTT assay by EA.hy926 human endothelial cells. The cytocompatibility results showed that human cells induced more favorable attachment and proliferation behavior on hydrophilic PLA composite scaffold than that of pristine PLA. Hence, PVA coating resulted in an increase in initial human cell attachment and proliferation. We believe that the novel PVA-coated PLA nanofiber scaffold developed in this study, could be a promising high performance biomaterial in regeneration medicine.

CASE DESCRIPTION A 3-year-old male Cocker Spaniel renal transplant recipient was readmitted 39 weeks after transplantation because of acute clinical signs of pollakiuria, intermittent vomiting, decreased appetite, lethargy, and mild fever. CLINICAL FINDINGS Hydronephrosis and hydroureter were observed with ultrasonography and contrast cystography, and a diagnosis of vesicoureteral reflux (VUR) was made. Urinary tract infection (UTI) caused by Escherichia coli was also diagnosed on the basis of results of urine culture. TREATMENT AND OUTCOME Despite treatment of the UTI with an appropriate antimicrobial for 6 weeks, the VUR persisted and the UTI recurred 9 weeks after cessation of antimicrobial treatment. Therefore, surgical correction by means of revision extravesicular ureteroneocytostomy was performed. Both VUR and hydronephrosis resolved after surgery. No recurrences of clinical signs of urinary tract complications were observed during the subsequent 22-month follow-up period. CLINICAL RELEVANCE Results suggested that ureteral reimplantation with an extravesicular technique incorporating a long submucosal tunnel may be an effective treatment for VUR when medical management fails in canine renal transplant recipients with recurrent UTIs.